Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QT Interval Evaluation of LPC-01 in Healthy Japanese Adult Males
jRCT2080222322Phase 1
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of LPC-01 in hyperlipidemia (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: QT interval change with LPC-01.
02
Drugs
LPC-01
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on jRCT2080222322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222322.